Literature DB >> 25335837

Making the case for multipurpose prevention technologies: the socio-epidemiological rationale.

H Boonstra1, S Barot, M Lusti-Narasimhan.   

Abstract

This paper summarises the public health rationale for multipurpose prevention technologies (MPTs) by examining recent epidemiological data and trends in sexual and reproductive health indicators. MPTs are products that combine protection against unintended pregnancy, HIV and other sexually transmitted infections. The successful introduction of new woman-controlled MPTs provides a compelling response to the multiple sexual and reproductive health risks that women face worldwide.
© 2014 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Multipurpose prevention technologies; research and development; sexual and reproductive health

Mesh：

Year:  2014        PMID： 25335837     DOI： 10.1111/1471-0528.12851

Source DB:  PubMed          Journal:  BJOG        ISSN： 1470-0328            Impact factor:   6.531


  10 in total

1.  Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.

Authors:  Jenna S Hynes; Anandi N Sheth; Eva Lathrop; Jessica M Sales; Lisa B Haddad
Journal:  J Womens Health (Larchmt)       Date:  2019-01-04       Impact factor: 2.681

2.  Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe.

Authors:  Alexandra M Minnis; Juliane Etima; Petina Musara; Erica N Browne; Prisca Mutero; Doreen Kemigisha; Nyaradzo M Mgodi; Clemensia Nakabiito; Mary Kate Shapley-Quinn; Marie C D Stoner; Miriam Hartmann; Nicole Macagna; Jeanna Piper; Ariane van der Straten
Journal:  AIDS Behav       Date:  2022-06-08

Review 3.  Lectins as Promising Therapeutics for the Prevention and Treatment of HIV and Other Potential Coinfections.

Authors:  Milena Mazalovska; J Calvin Kouokam
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

4.  Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.

Authors:  Alexandra M Minnis; Sarah T Roberts; Kawango Agot; Rachel Weinrib; Khatija Ahmed; Kgahlisho Manenzhe; Fredrick Owino; Ariane van der Straten
Journal:  AIDS Behav       Date:  2018-08

5.  Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.

Authors:  Kathleen L Vincent; John A Moss; Mark A Marzinke; Craig W Hendrix; Peter A Anton; Richard B Pyles; Kate M Guthrie; Lauren Dawson; Trevelyn J Olive; Irina Butkyavichene; Scott A Churchman; John M Cortez; Rob Fanter; Manjula Gunawardana; Christine S Miller; Flora Yang; Rochelle K Rosen; Sara E Vargas; Marc M Baum
Journal:  PLoS Med       Date:  2018-09-28       Impact factor: 11.069

6.  Two Birds with One Stone: Health Care Providers' Perspectives about Prevention Technologies in Kenya and South Africa.

Authors:  Alexandra Lutnick; Mary Kate Shapley-Quinn; Kgahlisho Nozibele Manenzhe; Jacob Onyango; Kawango Agot; Khatija Ahmed; Ariane van der Straten
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

7.  In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection.

Authors:  Farnaz Minooei; Joel R Fried; Joshua L Fuqua; Kenneth E Palmer; Jill M Steinbach-Rankins
Journal:  Int J Nanomedicine       Date:  2021-02-15

8.  Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.

Authors:  James M Smith; John A Moss; Priya Srinivasan; Irina Butkyavichene; Manjula Gunawardana; Rob Fanter; Christine S Miller; Debbie Sanchez; Flora Yang; Shanon Ellis; Jining Zhang; Mark A Marzinke; Craig W Hendrix; Amita Kapoor; Marc M Baum
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

9.  The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention.

Authors:  Ariane van der Straten; Kawango Agot; Khatija Ahmed; Rachel Weinrib; Erica N Browne; Kgahlisho Manenzhe; Fredrick Owino; Jill Schwartz; Alexandra Minnis
Journal:  J Int AIDS Soc       Date:  2018-03       Impact factor: 5.396

Review 10.  Pre-exposure prophylaxis (PrEP) in an era of stalled HIV prevention: Can it change the game?

Authors:  Robyn Eakle; Francois Venter; Helen Rees
Journal:  Retrovirology       Date:  2018-04-02       Impact factor: 4.602
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.